Cooper Companies, Inc.
Congress has disclosed 9 buys and 4 sells of COO (Cooper Companies, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying COO and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | $69.77 | $59.55 | -14.6% | underwater |
| Gilbert Cisneros | 2026-06-05 | $67.34 | $59.55 | -11.6% | underwater |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
13 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2026-06-05 | 27 days | +10.2% | $1K–$15K 0.1% of NW |
24.5 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2026-05-29 | 7 days | +10.0% | $1K–$15K 0.1% of NW |
32.9 | ↗ filing |
| Alan Armstrong | Senate | BUY | Self | 2026-03-27 | 116 days | +1.8% | $1K–$15K | 99.1 | ↗ eFD |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2025-12-10 | 30 days | +3.4% | $1K–$15K 0.1% of NW |
64.1 | ↗ filing |
| Rob Bresnahan | House | SELL | Self · JP Morgan Brokerage Account | 2025-05-15 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.5 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2020-02-25 | 5 days | — | $1K–$15K 0.2% of NW |
10.6 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-08-30 | 2 days | — | $1K–$15K 0.2% of NW |
15.7 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-03-20 | 12 days | — | $1K–$15K 0.2% of NW |
22.3 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-03-14 | 18 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-01-24 | 0 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Thomas Suozzi | House | SELL | Self | 2017-01-05 | 25 days | — | $15K–$50K 0.3% of NW |
90.9 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2015-04-20 | 12 days | — | $15K–$50K | 56.6 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2014-10-22 | 5 days | — | $15K–$50K | 90.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in COO — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in COO, 1 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-09-16 | Kurzius Lawrence Erik | Director | BUY | $549K | ↗ EDGAR |
| 2026-09-14 | Kurzius Lawrence Erik | Director | BUY | $539K | ↗ EDGAR |
| 2026-09-14 | Rosebrough Walter M Jr | Director | BUY | $163K | ↗ EDGAR |
| 2026-09-11 | Rosebrough Walter M Jr | Director | BUY | $379K | ↗ EDGAR |
| 2026-09-11 | Keel Paul A | Director | BUY | $250K | ↗ EDGAR |
| 2025-12-22 | Lucchese Cynthia L | Director | BUY | $150K | ↗ EDGAR |
| 2025-12-18 | Rivas Maria | Director | BUY | $82K | ↗ EDGAR |
| 2025-12-17 | Kurzius Lawrence Erik | Director | BUY | $165K | ↗ EDGAR |
| 2025-12-16 | White Albert G III | C-suite | BUY | $808K | ↗ EDGAR |
| 2025-12-16 | Sheffield Holly R | C-suite | BUY | $99K | ↗ EDGAR |
| 2025-09-29 | Kurzius Lawrence Erik | Director | BUY | $137K | ↗ EDGAR |
| 2025-09-05 | Warner Gerard H III | C-suite | BUY | $100K | ↗ EDGAR |
| 2025-09-05 | White Albert G III | C-suite | BUY | $684K | ↗ EDGAR |
| 2025-09-02 | Andrews Brian G | C-suite | BUY | $100K | ↗ EDGAR |
| 2025-09-02 | McBride Daniel G | C-suite | BUY | $195K | ↗ EDGAR |
| 2024-09-19 | White Albert G III | C-suite | SELL | $12.0M | ↗ EDGAR |
| 2024-09-19 | White Albert G III | C-suite | SELL | $668K | ↗ EDGAR |
| 2024-09-10 | Ricupati Agostino | Other | SELL | $173K | ↗ EDGAR |
| 2024-09-05 | Andrews Brian G | C-suite | SELL | $2.6M | ↗ EDGAR |
| 2024-09-04 | McBride Daniel G | C-suite | SELL | $9.2M | ↗ EDGAR |
| 2024-09-04 | McBride Daniel G | C-suite | SELL | $2.8M | ↗ EDGAR |
| 2024-09-04 | McBride Daniel G | C-suite | SELL | $96K | ↗ EDGAR |
| 2024-03-18 | Ricupati Agostino | Other | SELL | $5K | ↗ EDGAR |
| 2024-03-18 | Ricupati Agostino | Other | SELL | $49K | ↗ EDGAR |
| 2024-03-18 | Ricupati Agostino | Other | SELL | $327K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-09-16 | Kurzius Lawrence Erik Director | BUY | $549K |
| ◆ insider | 2026-09-14 | Kurzius Lawrence Erik Director | BUY | $539K |
| ◆ insider | 2026-09-14 | Rosebrough Walter M Jr Director | BUY | $163K |
| ◆ insider | 2026-09-11 | Rosebrough Walter M Jr Director | BUY | $379K |
| ◆ insider | 2026-09-11 | Keel Paul A Director | BUY | $250K |
| Congress | 2026-06-05 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-05-29 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2025-12-22 | Lucchese Cynthia L Director | BUY | $150K |
| ◆ insider | 2025-12-18 | Rivas Maria Director | BUY | $82K |
| ◆ insider | 2025-12-17 | Kurzius Lawrence Erik Director | BUY | $165K |
| ◆ insider | 2025-12-16 | White Albert G III C-suite | BUY | $808K |
| ◆ insider | 2025-12-16 | Sheffield Holly R C-suite | BUY | $99K |
| Congress | 2025-12-10 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2025-09-29 | Kurzius Lawrence Erik Director | BUY | $137K |
| ◆ insider | 2025-09-05 | Warner Gerard H III C-suite | BUY | $100K |
| ◆ insider | 2025-09-05 | White Albert G III C-suite | BUY | $684K |
| ◆ insider | 2025-09-02 | Andrews Brian G C-suite | BUY | $100K |
| ◆ insider | 2025-09-02 | McBride Daniel G C-suite | BUY | $195K |
| Congress | 2025-05-15 | Rob Bresnahan | SELL | $1K–$15K |
| ◆ insider | 2024-09-19 | White Albert G III C-suite | SELL | $12.0M |
| ◆ insider | 2024-09-19 | White Albert G III C-suite | SELL | $668K |
| ◆ insider | 2024-09-10 | Ricupati Agostino Other | SELL | $173K |
| ◆ insider | 2024-09-05 | Andrews Brian G C-suite | SELL | $2.6M |
FAQ Common questions
How much has Congress traded COO?
9 disclosed buys and 4 sells of COO (Cooper Companies, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade COO?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.